NCT03114319 2026-04-16Dose Finding Study of TNO155 in Adult Patients With Advanced Solid TumorsNovartisPhase 1 Terminated227 enrolled
NCT04045496 2025-12-29A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid TumorsJacobio Pharmaceuticals Co., Ltd.Phase 1 Completed40 enrolled
NCT04121286 2025-05-20A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in ChinaAllist Pharmaceuticals, Inc.Phase 1 Completed17 enrolled
NCT03518554 2024-12-16A First in Human, Dose Escalation Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid TumorsJacobio Pharmaceuticals Co., Ltd.Phase 1 Completed38 enrolled
NCT03634982 2022-09-01Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid TumorsRevolution Medicines, Inc.Phase 1 Unknown133 enrolled